⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2151949 | 0.97 | ACLY (0.46) | — | |
| Ammonia Solution, Strong SCHEMBL27774285 | 0.97 | ACLY (0.46) | — | |
| SCHEMBL9837458 | 0.97 | ACLY (0.46) | — | |
| Carbonotrithioic Acid SCHEMBL28987370 | 0.88 | ACLY (0.41) | — | |
| SCHEMBL320771 | 0.84 | ACLY (0.54) | — | |
| SCHEMBL5075315 | 0.83 | ACLY (0.56) | — | |
| SCHEMBL9837397 | 0.81 | ACLY (0.54) | — | |
| SCHEMBL8571217 | 0.81 | ACLY (0.59) | — | |
| SCHEMBL127297 | 0.80 | — | — | |
| SCHEMBL6692276 | 0.79 | ACLY (0.63) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115389545-B | Variety grape wine identification method based on nuclear magnetic resonance hydrogen spectrum | 秦皇岛海关技术中心 | 2023-05-12 | — | — | CN | claimed |
| EP-1125919-B2 | Stabilized hydroxyalkyl(meth)acrylate | NIPPON CATALYTIC CHEM IND (JP) | 2016-12-28 | — | — | EP | claimed |
| EP-1125919-B1 | Stabilized hydroxyalkyl(meth)acrylate | NIPPON CATALYTIC CHEM IND (JP) | 2008-12-10 | — | — | EP | claimed |
| US-12503514-B2 | Autoimmune suppressor and application thereof | KEYMED BIOSCIENCES CO., LTD. (CN) | 2025-12-23 | — | — | US | disclosed |
| US-12351575-B2 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2025-07-08 | — | — | US | disclosed |
| CN-118679179-B | Long-acting GLP-1 polypeptide compound, composition and application thereof | 内蒙古博睿精创科技有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-119454908-A | Interleukin complex and use thereof | 北京志道生物科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118638210-B | Preparation method and application of long-acting PTH analogue | 南方医科大学第三附属医院（广东省骨科研究院） | 2024-11-15 | — | — | CN | disclosed |
| CN-118638210-A | Preparation method and application of long-acting PTH analogue | 南方医科大学第三附属医院（广东省骨科研究院） | 2024-09-13 | — | — | CN | disclosed |
| CN-113614102-B | Novel polypeptides and therapeutic uses thereof | 鸿绪生物医药科技（北京）有限公司 | 2024-08-13 | — | — | CN | disclosed |
| EP-4341238-A1 | PROCESS FOR PREPARING A POLYMERIZATION-PRONE COMPOUND | Röhm GmbH (DE) | 2024-03-27 | — | — | EP | disclosed |
| CN-102159207-A | Substituted pyrrolidine-2-carboxamides | HOFFMANN LA ROCHE | 2011-08-17 | — | — | CN | disclosed |
| EP-2340021-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | F. Hoffmann-La Roche AG (CH) | 2011-07-06 | — | — | EP | disclosed |
| US-20100152190-A1 | Substituted Pyrrolidine-2-Carboxamides | F. HOFFMANN-LA ROCHE AG (CH) | 2010-06-17 | — | — | US | disclosed |
| WO-2010031713-A1 | SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES | F. HOFFMANN-LA ROCHE AG (CH) | 2010-03-25 | — | — | WO | disclosed |
| US-20100075948-A1 | Substituted Pyrrolidine-2-Carboxamides | DING QINGJIE | 2010-03-25 | — | — | US | disclosed |
| EP-1729818-B1 | CONTRAST AGENTS FOR MAGNETIC RESONANCE IMAGING | CENTRE NAT RECH SCIENT (FR) | 2009-09-23 | — | — | EP | disclosed |
| US-5830936-A | THERMAL STABILIZERS FOR POLYOLEFINS AND ENGINEERING PLASTICS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1998-11-03 | — | — | US | disclosed |
| US-4732902-A | ENANTIOMORPHS AND CHEMICAL INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1988-03-22 | — | — | US | disclosed |
| EP-0246529-A2 | Long acting pyrrolo (2,3-g) isoquinolin-4-one derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1987-11-25 | — | — | EP | disclosed |